Artificial Inteligence Artificial Intelligence Biotech Technical Review 
N2Growth Blog
OCTOBER 23, 2023
With the constant advancements in technology and research, businesses in this sector require leaders who possess a deep understanding of the scientific landscape and the business acumen to drive growth and innovation. The life sciences industry is known for its unique challenges in recruiting and hiring.
Crunchbase News
JUNE 14, 2024
AI, biotech, space tech and cybersecurity also saw good-sized raises. Then, late last year, Cruise suspended its self-driving taxi program across the country after losing its permit to operate in San Francisco due to an incident with a pedestrian. Alzheon , $100M, biotech: Alzheon was the next biotech to raise big this week.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TechCrunch
MARCH 17, 2023
Best practices for leveraging artificial intelligence and machine learning in 2023 Zero-based budgeting: A proven framework for extending runway Image Credits: Getty Images It’s critical to make every dollar count in this environment, but pulling back too much in the wrong places can reduce momentum across your entire organization. “The
TechCrunch
MAY 20, 2022
Sunny Kumar, MD, MBA is a partner at GSR Ventures, an early-stage venture capital firm focused on healthcare technology with more than $3.5 Neurodegenerative disease is a major target for digital biomarker development due to a lack of easily accessible indicators that can help providers diagnose and manage these conditions.
CIO
APRIL 17, 2024
Normally, a CCO develops ideas about what the market needs and communicates them to a design team, which produces sketches to then be reviewed by the CCO. But what we’re learning from public announcements like these might just scratch the surface of gen AI use cases for the enterprise.
CIO
SEPTEMBER 18, 2023
When the timing was right, Chavarin honed her skills to do training and coaching work and eventually got her first taste of technology as a member of Synchrony’s intelligent virtual assistant (IVA) team, writing human responses to the text-based questions posed to chatbots.
Crunchbase News
JULY 24, 2024
Sure, there are some, including two $3 billion deals in Q2: Merck buying privately held biotech EyeBiotech for as much as $3 billion, and Hg buying AuditBoard for more than $3 billion. However, chipmakers also have caused a stir due to some of the big cash they’ve raised — or are about to raise. But there just haven’t been a lot.
Expert insights. Personalized for you.
179 
Let's personalize your content